These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 4441903

  • 21. Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloramphetamine.
    Fuller RW, Snoddy HD, Roush BW, Molloy BB.
    Neuropharmacology; 1973 Jan; 12(1):33-42. PubMed ID: 4687274
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neurochemical effects of danitracen (WA-355): mechanism of action.
    Hrishi Keshavan HJ, Gurbani NK, Dandiya PC.
    J Neural Transm; 1982 Jan; 53(2-3):217-21. PubMed ID: 6176681
    [Abstract] [Full Text] [Related]

  • 24. The effects of p-chloroamphetamine on instrumental conditioning in the rat.
    Rosen AJ, Freedman PE.
    Neuropharmacology; 1974 Jul; 13(7):585-90. PubMed ID: 4437732
    [No Abstract] [Full Text] [Related]

  • 25. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
    Peters DA, Tang S.
    Biochem Pharmacol; 1977 Jun 01; 26(11):1085-6. PubMed ID: 880261
    [No Abstract] [Full Text] [Related]

  • 26. Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-beta-carboline administration in mice.
    Buckholtz NS.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov 01; 314(3):215-21. PubMed ID: 6164934
    [No Abstract] [Full Text] [Related]

  • 27. The effect of pethidine on the 5-hydroxytryptamine and 5-hydroxyindoleacetic acid content of the mouse brain.
    Ahtee L, Saarnivaara L.
    J Pharm Pharmacol; 1971 Nov 01; 23(11):887-9. PubMed ID: 4400203
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cyproheptadine antagonism of p-chloroamphetamine hypothermia in mice.
    Burke DH, Ryan RP.
    Eur J Pharmacol; 1986 Sep 23; 129(1-2):195-8. PubMed ID: 2429848
    [Abstract] [Full Text] [Related]

  • 31. Reversible and irreversible effects of p-chloroamphetamine on brain serotonin in mice.
    Steranka L, Bessent R, Sanders-Bush E.
    Commun Psychopharmacol; 1977 Sep 23; 1(5):447-54. PubMed ID: 606480
    [No Abstract] [Full Text] [Related]

  • 32. Mechanism for the increase of brain 5-hydroxy-tryptamine and 5-hydroxyindoleacetic acid following delta9-tetrahydrocannabinol administration to rats.
    Segawa T, Takeuchi S, NAkano M.
    Jpn J Pharmacol; 1976 Jun 23; 26(3):377-9. PubMed ID: 978851
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM, Yellin TO.
    Res Commun Chem Pathol Pharmacol; 1971 Jun 23; 2(4):407-13. PubMed ID: 4400361
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.